166 related articles for article (PubMed ID: 32216216)
1. [Clinicopathological characterization of non-Hodgkin lymphoma of the prostate].
Zhou XD; Qi RX; Feng X; Liang Y; Wang XX; Bao W; Shi QL
Zhonghua Nan Ke Xue; 2019 Apr; 25(5):340-345. PubMed ID: 32216216
[TBL] [Abstract][Full Text] [Related]
2. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
3. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
4. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
[TBL] [Abstract][Full Text] [Related]
6. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
7. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
[TBL] [Abstract][Full Text] [Related]
8. [Primary Burkitt lymphoma of the seminal vesicle: a case report and review of the literature].
Ouyang J; Yin HL; Lu ZF; Zhou HB; Zhou XJ
Zhonghua Nan Ke Xue; 2009 Aug; 15(8):733-7. PubMed ID: 19852278
[TBL] [Abstract][Full Text] [Related]
9. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
[TBL] [Abstract][Full Text] [Related]
12. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
14. Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Graef CM; Gödel P; Falderbaum P; Balke-Want H; Simon F; Sieg N; Naendrup JH; Neumann MA; Gillessen S; Bröckelmann PJ; Eichenauer DA; Borchmann P; von Tresckow B; Heger JM
Eur J Haematol; 2022 May; 108(5):403-412. PubMed ID: 35090068
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
16. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2009 Dec; 27(4):182-5. PubMed ID: 19670467
[TBL] [Abstract][Full Text] [Related]
17. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
Nomura Y; Karube K; Suzuki R; Ying G; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Cancer Sci; 2008 Feb; 99(2):246-52. PubMed ID: 18271922
[TBL] [Abstract][Full Text] [Related]
18. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.
Soldini D; Montagna C; Schüffler P; Martin V; Georgis A; Thiesler T; Curioni-Fontecedro A; Went P; Bosshard G; Dehler S; Mazzuchelli L; Tinguely M
Ann Oncol; 2013 Jan; 24(1):193-201. PubMed ID: 22967991
[TBL] [Abstract][Full Text] [Related]
19. The accuracy of diagnosing Burkitt lymphoma in serous effusion specimen: A cytological-histological correlation with ancillary studies.
Li J; Zhang W; Zhao S; Jiang Y; Liu W; Zhu X; Su X
Cytopathology; 2019 Jul; 30(4):378-384. PubMed ID: 30983044
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
